Status:

RECRUITING

ORIGIN® vs. VANGUARD® PS Observational Study

Lead Sponsor:

Symbios Orthopedie SA

Conditions:

Arthroplasty

Replacement

Eligibility:

All Genders

18+ years

Brief Summary

The study objective is to assess patient satisfaction after the surgery with a patient match CE marked implant (ORIGIN®) versus off-the-shelf (VANGUARD PS) device, and to document the clinical and dev...

Detailed Description

This is a prospective, comparative, randomized, double arm, monocentric, observational, post-market study with 140 subjects with 2 years follow-up.

Eligibility Criteria

Inclusion

  • Inclusion/exclusion criteria

Exclusion

    Key Trial Info

    Start Date :

    March 25 2021

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    February 1 2027

    Estimated Enrollment :

    140 Patients enrolled

    Trial Details

    Trial ID

    NCT04728542

    Start Date

    March 25 2021

    End Date

    February 1 2027

    Last Update

    October 4 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University Medical Center of Johannes Gutenberg-University Mainz

    Mainz, Germany, 55131

    ORIGIN® vs. VANGUARD® PS Observational Study | DecenTrialz